...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZEN-3694 mCRPC Trial Status
6
Oct 24, 2017 11:18AM
1
Oct 25, 2017 09:02AM

This star factory anology is very interesting,  If Zenith epigenetics could sell off each indication molecule for each disease I can only imagine what they could for each one and how many they have

 

IF Zen3694 gets sold separately the value of Zenith IMO is greatly enhanced rather than one large BP buying the entire company and IP for one large price,  If the science is working perfectly this company could be worth a huge amount in a few years!

2
Oct 26, 2017 10:24AM
5
Oct 26, 2017 12:13PM

Nov 02, 2017 03:38PM

Nov 02, 2017 04:29PM

Nov 03, 2017 10:49AM

Nov 03, 2017 10:58AM

Nov 03, 2017 12:07PM
2
Nov 03, 2017 03:45PM
2
Nov 03, 2017 04:23PM
5
Nov 18, 2017 07:45PM
Share
New Message
Please login to post a reply